Synergy Pharmaceuticals Inc fka SGYPQ

[Opti Mist]

Seeking Alpha article at: https://seekingalpha.com/article/4104279-synergy-pharma-takes-money-make-money?app=1&auth_param=38sjt:1cqu4bs:b3e85c056deb66070e76f498bb2ce708&uprof=45

Summary
Synergy Pharmaceuticals has just secured a $300 million debt financing deal from CRG LP.
Synergy's 9.5% interest rate should be seen as favorable, and after tax deductions, the effective rate will be even lower.
Synergy has sufficient cash until the end of 2019 where they will also break-even, while Ironwood has remained unprofitable for 5+ years.
Synergy has still refused to give up any Worldwide rights or royalties to outside parties, which carries significant value.
A debt financing deal doesn't kill a potential merger situation, as Relypsa announced a debt financing deal two months before their buyout.

Opti